May 01, 2007
Nanotechnology is used to make hundreds of different consumer products and is already revolutionizing medicine. The Wilson Center's Project on Emerging Nanotechnologies, supported by the Pew Charitable Trusts, is assessing the enormous potential while keeping an eye on environmental and safety concerns.
Apr 26, 2007
Given the incredible promise of the fast emerging field—and the billions in public and private investment that it has attracted—the Project on Emerging Nanotechnologies has launched a series of newsletters and podcasts focused on progress toward exciting applications on the horizon of nanotechnology.
Jan 04, 2007
"Prioritizing nanotechnology risk research isn't rocket science," says Project on Emerging Nanotechnologies chief scientist Andrew Maynard.
Research Needs and Priorities Related to the Environmental, Health, and Safety Aspects of Engineered Nanoscale Materials
Jan 03, 2007
Testimony by Andrew D. Maynard, Ph.D.Chief Science Advisor Project on Emerging Nanotechnologies
Comments by David Rejeski in advance of the meeting on Research Needs and Priorities Related to the Environmental, Health, and Safety Aspects of Engineered Nanoscale Materials
Jan 03, 2007
Dec 05, 2006
"Nanoscale science and engineering promise to be as important as the steam engine, the transistor, and the Internet, and have the potential to revolutionize all other technologies" according to Neal Lane, former science advisor to U.S. President Bill Clinton. "But that outcome is not guaranteed."
Nov 27, 2006
Tell a friend you are buying them a nanotechnology gift for the holidays, and visions of Star Trek collectables or geeky electronic toys may start to dance in their heads. But nanotechnology gifts can include everything from silver nanoparticle enhanced food storage containers to to fleece jackets and gloves from the Lands' End™ catalog—with Nano-Tex® Resists Static treatment.
Oct 05, 2006
A new report released today, Regulating the Products of Nanotechnology: Does FDA Have the Tools It Needs? by Michael Taylor, a former Deputy Commissioner for Policy at the Food and Drug Administration (FDA), examines the agency's capacity to properly regulate new products containing nanotechnology materials—including food, drugs, medical devices, dietary supplements and cosmetics.
Sep 21, 2006
Today at a hearing of the U.S. House of Representatives Committee on Science, Dr. Andrew Maynard testified that nanotechnology is being jeopardized by the lack of a clear federal strategy for examining possible environmental, health and safety risks and by inadequate funding for this work.
Sep 19, 2006
Research findings released from the first major national poll on nanotechnology in more than two years indicate that while more Americans are now aware of the emerging science, the majority of the public still has heard little to nothing about it.